Nippon India Mutual Fund launches new fund offer of Nippon India Nifty Pharma ETF
As of now there 12 pharma schemes that are focused on pharma stocks. These schemes put together manage assets worth Rs 14,949 crore.
Read moreAs of now there 12 pharma schemes that are focused on pharma stocks. These schemes put together manage assets worth Rs 14,949 crore.
Read moreThe scheme is an ideal vehicle for those who are looking to invest in large cap stocks present in Nifty 50 and want to benefit from broad-based rally in stocks.
Read moreFuture Generali Money Back Super Plan is a traditional non-participating money back plan.
Read morePPFAS Mutual Fund closed the new fund offer of Parag Parikh Conservative Hybrid Fund for subscription at the closing hours of 21 May 2021. The scheme will reopen for ongoing subscription on 28 May 2021. The scheme aims to generate regular income through investments predominantly in debt and money market instruments. It also seeks to generate income and capital appreciation
Read moreThe fund will have a defined maturity date of April 30, 2026. At maturity, investors will get back their investment proceeds.
Read moreMinimum bid Lot is 27 equity shares and in multiples of 27 equity shares thereafter.
Read moreCanara Bank, a leading public sector bank, has retained its marginal cost of funds based lending rate (MCLR) on loans
Read moreRuPay SoftPoS will provide cost effective acceptance infrastructure to retailers at nominal cost
Read moreDSP Floater Fund is a one of its kind product in the short term category (duration band of 1 to 4 years) with interest rate hedge using paid position in OIS.
Read moreedge360 is a next generation portal that facilitates seamless transaction initiation, faster access to transaction status, generate investor statements, and monitor brokerage revenue using multiple parameters.
Read more